Clinical Trials Search | Clareo Health

Showing 1-1 of 1 trials

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

NCT05885412

This Phase 1 dose escalation trial will assess the safety and preliminary efficacy of a single dose intravenous infusion of RP-A601 in high-risk adult patients with PKP2-ACM.

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Rocket Pharmaceuticals Inc.9 participantsStarted Aug 2023

La Jolla, California, United States • Durham, North Carolina, United States • Philadelphia, Pennsylvania, United States

Data from ClinicalTrials.govTerms

Filters

Filters

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)